(2023). Evaluating Ethnic Variations in the Risk of Infections in People With Prediabetes and Type 2 Diabetes: A Matched Cohort Study. Diabetes Care. http://doi.org/10.2337/dc22-2394.
(2023). Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data. Plos One, 18, e0282513. http://doi.org/10.1371/journal.pone.0282513.
(2016). Mortality Among Adults With Intellectual Disability in England: Comparisons With the General Population. Am J Public Health. http://doi.org/10.2105/ajph.2016.303240.
(2016). Health characteristics and consultation patterns of people with intellectual disability: a cross-sectional database study in English general practice. Br J Gen Pract. http://doi.org/10.3399/bjgp16X684301.
(2017). Do health checks for adults with intellectual disability reduce emergency hospital admissions? Evaluation of a natural experiment. J Epidemiol Community Health. http://doi.org/10.1136/jech-2016-207557.
(2018). Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care. http://doi.org/10.2337/dc17-2131.
(2018). Glycemic Control and Risk of Infections Among People With Type 1 or Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. http://doi.org/10.2337/dc18-0287.
(2019). Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study. Diabetes Care. http://doi.org/10.2337/dc19-0848.
(2019). Longitudinal exposure of English primary care patients to pharmacogenomic drugs: an analysis to inform design of pre-emptive pharmacogenomic testing. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14100.
(2020). Development of a structured clinical pharmacology review for specialist support for management of complex polypharmacy in primary care. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14243.